MetaCap

Artivion (AORT) vs Beta Bionics (BBNX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Beta Bionics (BBNX) has outperformed Artivion (AORT) over the past year, losing 57.5% versus a loss of 59.8%. Artivion is the larger company by market cap ($886.0 million vs $726.3 million), about 1.2 times the size, while Beta Bionics is growing revenue faster (+53.9% vs +13.6%). Artivion converts more of its revenue into profit, with a net margin of 2.2% versus -73.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AORT-59.76%BBNX-57.48%
+8%-34%-76%
Nov 21, 20251 yearNov 20, 2026
AORT-41.34%BBNX-43.89%
+56%-6%-68%
Jan 27, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AORT versus BBNX key metrics
MetricAORTBBNX
Share price$18.16$13.36
Market cap$886.02M$726.34M
1-day change-2.00%+0.30%
YTD return-60.18%-56.15%
1-year return-59.76%-57.48%
5-year return-0.82%—
Forward P/E34.92—
EPS (TTM)$-0.36$-1.83
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$441.33M$100.25M
Revenue growth (YoY)+13.59%+53.94%
Net income (latest FY)$9.77M$-73.20M
Gross margin64.40%55.40%
Operating margin7.65%-71.50%
Net margin2.21%-73.02%
52-week high$48.25$32.71
52-week low$18.12$8.80
Distance from 52-week high-62.36%-59.16%
Analyst consensusstrong_buybuy
Avg. price target upside+111.84%+87.87%
Average volume671.97K1.21M
Shares outstanding48.79M54.37M
Employees1,800420
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Artivion is more profitable, keeping 2.2 cents of every revenue dollar as net income versus -73.0 cents for Beta Bionics.
  • Beta Bionics grew revenue faster in its latest fiscal year (+53.94% vs +13.59%).

About Artivion

AORT stock →

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Health Care · Medical/Dental Instruments · 1,800 employees

About Beta Bionics

BBNX stock →

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Health Care · Medical/Dental Instruments · 420 employees

AORT vs BBNX FAQ

Which is bigger, Artivion or Beta Bionics?

Artivion (AORT) is larger, with a market capitalization of $886.02M compared with $726.34M for Beta Bionics (BBNX).

Which stock has performed better over the past year, AORT or BBNX?

BBNX returned -57.48% over the past 12 months, compared with -59.76% for AORT (price return, excluding dividends). Past performance does not predict future results.

Are Artivion and Beta Bionics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons